Bioject Medical Technologies Inc. Sustainability Profile
Bioject Medical Technologies Inc., a leading innovator in the medical device industry, is headquartered in the United States. Founded in 1986, the company has established itself as a pioneer in needle-free injection technology, significantly enhancing patient comfort and safety. With a focus on developing advanced drug delivery systems, Bioject's core products include the Biojector® device, which offers a unique, efficient method for administering vaccines and medications without the use of needles. Operating primarily in North America and expanding into international markets, Bioject has achieved notable milestones, including partnerships with major pharmaceutical companies. The company’s commitment to innovation and quality has positioned it as a trusted name in the healthcare sector, making significant contributions to the evolution of drug delivery solutions.
DitchCarbon Score
How does Bioject Medical Technologies Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bioject Medical Technologies Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bioject Medical Technologies Inc.'s reported carbon emissions
Bioject Medical Technologies Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Bioject Medical Technologies may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate strategies to align with broader environmental goals.
How Carbon Intensive is Bioject Medical Technologies Inc.'s Industry?
How Carbon Intensive is Bioject Medical Technologies Inc.'s Location?
Bioject Medical Technologies Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bioject Medical Technologies Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boston Scientific
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.